Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Multiple switching between the biosimilar adalimumab PF-06410293 and reference adalimumab in patients with active rheumatoid arthritis: a phase 3, open-label, randomised, parallel-group study.
Journal: The Lancet. Rheumatology
Published: January 24, 2023
A global perspective on the challenges and opportunities in learning about rheumatic and musculoskeletal diseases in undergraduate medical education : White paper by the World Forum on Rheumatic and Musculoskeletal Diseases (WFRMD).
Journal: Clinical rheumatology
Published: December 17, 2018
Vasudhaiva Kutumbakam: The World Is One Family.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: January 29, 2018
Editorial: Ensuring the Future of Rheumatology: A Multi-Dimensional Challenge and Call to Action.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: January 23, 2018
Common language description of the term rheumatic and musculoskeletal diseases (RMDs) for use in communication with the lay public, healthcare providers and other stakeholders endorsed by the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR).
Journal: Annals of the rheumatic diseases
Published: October 19, 2017
Common Language Description of the Term Rheumatic and Musculoskeletal Diseases (RMDs) for Use in Communication With the Lay Public, Healthcare Providers, and Other Stakeholders Endorsed by the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR).
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: October 19, 2017
Showing 1-6 of 6
Last Updated: 09/26/2026